Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Central 5-HT2C receptor agonist exerts proerectile activity in two animal species

Oct. 9, 2000

Vardenafil's preclinical profile supports potential in ED; other PDE5 inhibitors in the pipeline

Oct. 9, 2000

IC-351 effective and safe as once-daily or on-demand therapy for ED

Oct. 6, 2000

Selective V2 receptor agonists from AHP and their use described in patents

Sep. 25, 2000

Recordati identifies potent and selective alpha1D-adrenoceptor antagonists based on BMY-7378

Sep. 21, 2000

Enrollment completed in pivotal phase III trial of Chondrogel

Sep. 21, 2000

Sanofi-Synthelabo discloses synthesis and use of new alpha-azacyclomethylquinolines

Sep. 19, 2000

Preclinical results in guinea pigs suggest novel mechanism of action for TAK-637

Sep. 18, 2000

Update on U.S. status of Zonagen's sexual dysfunction products

Sep. 15, 2000

Cystistat approved for expanded indications in Europe

Sep. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...